Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (1751)	2/15/2007 3:38:53 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

Hi Ian, Re: MNTA I don't follow the stock closely, but the Feb 9 drop apparently was after the news that Sanofi-Aventis lost a patent case over Lovenox. biz.yahoo.com bigcharts.marketwatch.com It is now trying to find support at the 13.85 level after it retested the 13.78 level at the opening. Volume remains relatively low around 506Ks, nothing like the 6.9M on Feb 9 <g> The 4thQ results showed a larger loss of $0.45/shr in spite of a 24% improvement on revenues to 4M. The stock trades around 3xBV with little LTD.Insiders reportedly hold close to 30% & funds > 35% The SI came down about 10% in the last month, but is still > 8x its AvgDVol Back in Oct it started a PI on M118 for acute coronary syndromes The loss is expected to increase a little to $1.65 on the current Yr. & to be cut to $0.25/shr in 2008 It seems that it may find support at the 12.75 to 13 level & remain above its Jun 2004 IPO price. As you may recall, its Jul 2005 H was 34.60 <g> bigcharts.marketwatch.com RAGL Bernard